Regis Corp (RGS) 12.64 $RGS Upgrade Alert for Regis

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Regis Corp (RGS) 12.64 $RGS

Upgrade Alert for Regis (RGS)
Comtex SmarTrend(R) - Fri May 20, 3:20AM CDT
Regis (NYSE:RGS) was upgraded from Underweight to Neutral at Piper Jaffray today. The stock closed yesterday at $12.36 on volume of 1.3 million shares, above average daily volume of 201,000. There is potential upside of 53.7% for shares of Regis based on a current price of $12.36 and an average consensus analyst price target of $19.00. Regis shares should first meet resistance at the 200-day moving average (MA) of $14.43 and find additional resistance at the 50-day MA of $14.90.
RGS: 12.64 (-0.36)

Downgrade Alert for Regis (RGS)
Comtex SmarTrend(R) - Fri May 20, 3:18AM CDT
Regis (NYSE:RGS) was downgraded from Neutral to Underweight at Piper Jaffray today. The stock closed yesterday at $12.36 on volume of 1.3 million shares, above average daily volume of 201,000. Regis Corporation operates and franchises hair and retail product salons. Regis' salons operate under the Regis Hairstylists, Supercuts, MasterCuts, Trade Secret, and SmartStyle banners. The Company operates worldwide.
RGS: 12.64 (-0.36)

Regis Corporation Issues Clarification to Piper Jaffray Research Report
BusinessWire - Thu May 19, 9:44AM CDT
Regis Corporation (NYSE:RGS), a leader in the haircare industry, whose primary business is owning, operating and franchising hair salons, announced that before the stock market opened today, Piper Jaffray issued a report on Regis Corporation. In its report, Piper Jaffray significantly lowered its estimates by incorporating up to $81 million of incremental costs associated with the new U.S. Department of Labor overtime rules, issued yesterday. Regis Corporation has been following the status of these rule changes for the past several months and analyzing the potential impact of the new rules to the company's profitability. The Company's assessment suggests these new rules could increase our costs by up to $5 million per year, and is considering alternative mitigation strategies to reduce this increase. The large difference between Piper Jaffray's report and the Company's estimates is due to the fact that our salon managers and a large portion of our district leaders are already treated as hourly employees. Piper Jaffray's estimates assumed these employees were salaried employees.
RGS: 12.64 (-0.36)

Regis (RGS) Stock Down on Wider-than-Expected Q3 Loss
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 8:31AM CDT
Regis Corp. (RGS) reported dismal results for the third quarter of fiscal 2016.
HZO: 16.51 (-0.88), SBH: 28.31 (-0.79), ULTA: 239.16 (-2.92), RGS: 12.64 (-0.36)

Regis Reports Third Quarter 2016 Results
BusinessWire - Thu Apr 28, 5:00AM CDT
Regis Corporation (NYSE: RGS), a leader in the haircare industry, whose primary business is owning, operating and franchising hair salons, today reported results for its third fiscal quarter ended March 31, 2016 versus the prior year as noted below.
RGS: 12.64 (-0.36)

Regis to Issue Third Quarter Results on April 28, 2016
BusinessWire - Mon Apr 18, 5:03PM CDT
Regis Corporation (NYSE:RGS), a leader in the haircare industry, whose primary business is owning, operating and franchising hair salons, will issue financial results for the third fiscal quarter ended March 31, 2016 before the market opens on Thursday, April 28, 2016. Following the release, the Company will host a presentation via webcast for investors beginning at 9:00 a.m. Central time to discuss current corporate developments and financial results.
RGS: 12.64 (-0.36)

Supercuts Ranked #1 Haircare Franchise and Third Best Franchise Overall In Entrepreneur Magazine's 37th Annual "Franchise 500®"
PR Newswire - Tue Feb 02, 8:07AM CST
For the eighth year in a row, Supercuts, one of the largest and most iconic hair salon brands in the United States, has been ranked the number one haircare franchise in the country in Entrepreneur magazine's 2016 Franchise 500® and the third best franchise opportunity overall, up two spots from the brand's 2015 overall ranking.
RGS: 12.64 (-0.36)

Regis Posts Earnings in Q2, Misses Revenues; Comps Grow
Zacks Equity Research - Zacks Investment Research - Fri Jan 29, 10:05AM CST
Regis Corp. (RGS) reported earnings of 3 cents per share in the second quarter of fiscal 2016 backed by comparable sales (comps) growth.
BGFV: 9.33 (+0.27), KAR: 40.15 (-0.63), ULTA: 239.16 (-2.92), RGS: 12.64 (-0.36)

Regis reports 2Q loss
Automated Insights - Thu Jan 28, 5:13AM CST
EDINA, Minn. (AP) _ Regis Corp. (RGS) on Thursday reported a loss of $14 million in its fiscal second quarter.
RGS: 12.64 (-0.36)

Regis Reports Second Quarter 2016 Results
BusinessWire - Thu Jan 28, 5:00AM CST
Regis Corporation (NYSE: RGS), a leader in the haircare industry, whose primary business is owning, operating and franchising hair salons, today reported results for its second fiscal quarter ended December 31, 2015 versus the prior year as noted below.
RGS: 12.64 (-0.36)

Regis to Issue Second Quarter Results on January 28, 2016
BusinessWire - Mon Jan 18, 5:23AM CST
Regis Corporation (NYSE:RGS), a leader in the haircare industry, whose primary business is owning, operating and franchising hair salons, will issue financial results for the second fiscal quarter ended December 31, 2015 before the market opens on Thursday, January 28, 2016. Following the release, the Company will host a presentation via webcast for investors beginning at 9:00 a.m. Central time to discuss current corporate developments and financial results.
RGS: 12.64 (-0.36)

Bed Bath & Beyond Q3 Earnings Falls Y/Y, Meets Estimates
Zacks Equity Research - Zacks Investment Research - Fri Jan 08, 8:10AM CST
Bed Bath & Beyond (BBBY) posts third-quarter fiscal 2015 results.
CST: 43.05 (-0.77), BBBY: 43.31 (-0.52), ULTA: 239.16 (-2.92), RGS: 12.64 (-0.36)

Can Bed Bath & Beyond's Growth Plans Combat the Hurdles?
Zacks Equity Research - Zacks Investment Research - Mon Dec 28, 8:40AM CST
Bed Bath & Beyond (BBBY) has been struggling with its performance.
CST: 43.05 (-0.77), BBBY: 43.31 (-0.52), ULTA: 239.16 (-2.92), RGS: 12.64 (-0.36)

Bed Bath & Beyond Falls after Dismal Preliminary Q3 View
Zacks Equity Research - Zacks Investment Research - Wed Dec 23, 9:30AM CST
Shares of Bed Bath & Beyond Inc. (BBBY) declined 6.3% yesterday in after hour trading session after the company lowered its third-quarter fiscal 2015 projections.
CST: 43.05 (-0.77), BBBY: 43.31 (-0.52), ULTA: 239.16 (-2.92), RGS: 12.64 (-0.36)

Avon (AVP) Sells Stake to Cerberus to Enhance Performance
Zacks Equity Research - Zacks Investment Research - Fri Dec 18, 9:30AM CST
Avon Products (AVP) recently penned a deal with Cerberus Capital Management
AVP: 3.85 (-0.39), ULTA: 239.16 (-2.92), EL: 89.73 (-5.22), RGS: 12.64 (-0.36)

Avon (AVP) Slashed to Strong Sell on Persistent Weakness
Zacks Equity Research - Zacks Investment Research - Wed Dec 16, 10:50AM CST
Zacks Investment Research downgraded Avon Products (AVP) to Strong Sell
AVP: 3.85 (-0.39), ULTA: 239.16 (-2.92), EL: 89.73 (-5.22), RGS: 12.64 (-0.36)

Uptrend Call Working As Regis Stock Rises 17.8% (RGS)
Comtex SmarTrend(R) - Tue Dec 08, 9:47AM CST
SmarTrend identified an Uptrend for Regis (NYSE:RGS) on October 23rd, 2015 at $13.00. In approximately 2 months, Regis has returned 17.85% as of today's recent price of $15.32.
RGS: 12.64 (-0.36)

ULTA Salon (ULTA) Looks Good: Stock Adds 12.8% in Session
Zacks Equity Research - Zacks Investment Research - Mon Dec 07, 7:25AM CST
ULTA Salon, Cosmetics & Fragrance, Inc. (ULTA) saw its shares rise almost 13% on the day.
ULTA: 239.16 (-2.92), RGS: 12.64 (-0.36)

Supercuts Thanks a Million Guests
PR Newswire - Wed Dec 02, 5:55AM CST
Supercuts, a salon industry leader in affordable haircare services, is pleased to announce that more than 1 million guests throughout the United States and Canada have checked in online via Supercuts.com or on the mobile app. An early holiday gift, the milestone arrived well before the one-year anniversary of offering online check-in to guests.
RGS: 12.64 (-0.36)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 61

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 144

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 69

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 181

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 28

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 80

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 149

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 252

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 331

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Warner Bros. Discovery's Remarkable Stock Surge Explained

Updated Category News Views 309

Warner Bros. Discovery Experiences Impressive Stock Surge Warner Bros. Discovery Inc. (NASDAQ: WBD) has been making headlines recently, with its stock surging dramatically. Investors and market enthusiasts are keenly observing this upward trend, particularly following a substantial rally. Record-Breaking Rally The company achieved an incredible milestone with its largest...

Continue Reading
Stellantis Reports 20% Q3 Shipment Drop, Market Reactions

Updated Category News Views 98

Stellantis Faces Significant Q3 Shipment Decline Stellantis (EPA: STLAM) (NYSE: STLA) recently reported a 20% drop in global shipments for the third quarter, prompting a notable reaction in the markets. The decline has been attributed to several factors including strategic inventory reduction measures and delays in the release of new models. During this challenging...

Continue Reading
Stifel Affirms Buy Rating on Elanco Amid New Drug Approval

Updated Category News Views 70

Stifel Stands Firm on Elanco Animal Health Stifel, a prominent financial services firm, has recently reaffirmed its Buy rating for Elanco Animal Health (NYSE: ELAN) and has kept its price target at $20.00 per share. This decision comes on the heels of the U.S. Food and Drug Administration's (FDA) approval of Elanco's new drug, Zenrelia, which serves as a significant boost...

Continue Reading
ChargePoint and Siemens Drive EV Infrastructure Innovation

Updated Category News Views 94

ChargePoint and Siemens Lead the Charge in Clean Tech The clean tech revolution is moving at an impressive pace, particularly with the growth of electric vertical takeoff and landing (eVTOL) aircraft and electric vehicle (EV) infrastructure. Companies like ChargePoint Holdings Inc (NYSE: CHPT) and Siemens AG (OTCPK: SIEGY) are crucial in shaping a sustainable future for...

Continue Reading
Elevance Health Faces Class Action: Investors Seek Remedies

Updated Category News Views 259

Opportunities for Investors in Elevance Health Class Action The recent developments surrounding Elevance Health, Inc. have prompted considerable attention, particularly among investors who have experienced substantial financial losses. The law firm Robbins Geller Rudman & Dowd LLP has initiated a class action lawsuit targeting Elevance Health, which operates in the health...

Continue Reading